Swiss Medical Weekly

The Swiss Medical Weekly is a peer-reviewed open access medical journal published by the SMW supporting association. It was established in 1871 as the Correspondenz-Blatt für Schweizer Aerzte, then renamed to Schweizerische Medizinische Wochenschrift, before obtaining its current title in 2001. SMW was one of the first journals to adhere to the principles of Diamond open access (also known as Platinum Open Access). The editors-in-chief are Adriano Aguzzi and Gérard Waeber.

Swiss Medical Weekly

Discipline	Medicine
Language	English
Edited by	Adriano Aguzzi and Gérard Waeber
Publication details
Former name(s)	Correspondenz-Blatt für Schweizer Aerzte, Schweizerische Medizinische Wochenschrift
History	1871-present
Publisher	SMW supporting association
Frequency	continuous online
Impact factor	4.203 (2021)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Swiss Med. Wkly.
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus · W&L
ISSN	1424-3997
OCLC no.	807721576
Links
Journal homepage Online archive

Abstracting and indexing

The journal is abstracted and indexed in:

• Directory of Open Access Journals
• EMBASE
• MEDLINE/PubMed
• Science Citation Index Expanded

According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.203.^[1]

Important papers

In 1957 Roland Kuhn published an observational study on the effectiveness of Imipramine in treating Depression (mood). ^[2] Other examples are the fundoplication described by Rudolf Nissen^[3] in 1956 and the first description of a haemolytic-uraemic syndrome by Conrad Gasser in 1955.^[4]

See also

• Revue Médicale Suisse